Tyler-Stone Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-148
Closed -$11.6K – 693
2024
Q2
$11.6K Hold
148
– – ﹤0.01% 631
2024
Q1
$12.9K Hold
148
– – 0.01% 607
2023
Q4
$12.2K Hold
148
– – 0.01% 604
2023
Q3
$12K Hold
148
– – 0.01% 569
2023
Q2
$13K Buy
+148
New +$12.7K 0.01% 551
2022
Q4
$9K Sell
115
-157
-58% -$12.7K 0.01% 578
2022
Q3
$22K Sell
272
-2,765
-91% -$248K 0.02% 418
2022
Q2
$273K Buy
3,037
+1
+0% +$101 0.18% 116
2022
Q1
$337K Sell
3,036
-472
-13% -$49.9K 0.19% 113
2021
Q4
$363K Buy
+3,508
New +$406K 0.19% 105

Other funds holding MDT

Tyler-Stone Wealth Management's MDT Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Medtronic (MDT) in Q3 2024, closing a stake of 148 shares — an estimated $11.6K sold.

Tyler-Stone Wealth Management first reported a position in MDT in Q4 2021 and held it in 10 quarters. The position peaked at $363K in Q4 2021. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 148 Medtronic shares in Q3 2024, an estimated $11.6K.
  • Tyler-Stone Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Medtronic position peaked at $363K in Q4 2021.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.